| AnGes, Inc. | — | -5.1 | — | 2025 |
| ASKA Pharmaceutical Holdings Co., Ltd. | 71.1 | 5.6 | 7.9% | 2026 |
| Astellas Pharma Inc. | 888.1 | 368 | 41.4% | 2026 |
| BrightPath Biotherapeutics Co., Ltd | 0 | -1.3 | -1,553,513.1% | 2026 |
| Carna Biosciences, Inc. | 0.6 | -2.2 | -375% | 2025 |
| Chiome Bioscience Inc. | 0.6 | -1 | -165.6% | 2025 |
| Chordia Therapeutics Inc. | — | -1.8 | — | 2025 |
| CHUGAI PHARMACEUTICAL CO., LTD. | 1,246.1 | 401.3 | 32.2% | 2025 |
| CHUKYOIYAKUHIN CO.,LTD. | 6.6 | 0.1 | 1.3% | 2026 |
| Cuorips Inc. | 0.2 | -1 | -485.3% | 2026 |
| Cyfuse Biomedical K.K. | 0.2 | -0.8 | -330.7% | 2025 |
| D.Western Therapeutics Institute, Inc. | 0.4 | -0.6 | -163.1% | 2025 |
| DAIICHI SANKYO COMPANY, LIMITED | 1,807 | 447.9 | 24.8% | 2026 |
| Daito Pharmaceutical Co.,Ltd. | 50.7 | 3.1 | 6.2% | 2026 |
| Delta-Fly Pharma,Inc. | — | -1.6 | — | 2026 |
| EIKEN CHEMICAL CO.,LTD. | 41.9 | 3.7 | 8.8% | 2026 |
| Eisai Co., Ltd. | 386.3 | 20.8 | 5.4% | 2026 |
| Fuji Pharma Co.,Ltd. | 51.7 | 3 | 5.8% | 2025 |
| FunPep Company Limited | — | -1.9 | — | 2025 |
| Fuso Pharmaceutical Industries, Ltd. | 62.3 | 2 | 3.2% | 2026 |
| GNI Group Ltd. | 0 | -1.8 | -8,666.7% | 2025 |
| HEALIOS K.K. | 0.7 | -2.4 | -345.2% | 2025 |
| Heartseed Inc. | 3 | 0.2 | 6.3% | 2025 |
| Immuno-Biological Laboratories Co., Ltd. | 1 | 0.3 | 32.7% | 2026 |
| Innovacell Inc. | — | -2.9 | — | 2025 |
| J-Pharma Co.,Ltd. | — | -2.5 | — | 2026 |
| JCR Pharmaceuticals Co.,Ltd. | 40.3 | 2.2 | 5.5% | 2026 |
| K Pharma, Inc. | — | -1 | — | 2025 |
| KAKEN PHARMACEUTICAL CO., LTD. | 76.9 | 2.1 | 2.8% | 2026 |
| Kidswell Bio Corporation | 6.6 | -0.4 | -6.3% | 2026 |
| KISSEI PHARMACEUTICAL CO., LTD. | 97.4 | 14 | 14.3% | 2026 |
| KOA SHOJI HOLDINGS CO.,LTD. | 24.7 | 3.7 | 15.2% | 2026 |
| Kohjin Bio Co., Ltd. | 4.9 | 0.3 | 5.1% | 2026 |
| Kringle Pharma, Inc. | 0.1 | -0.9 | -1,268.8% | 2025 |
| Kubota Pharmaceutical Holdings Co., Ltd. | — | -0.7 | — | 2025 |
| KYORIN Pharmaceutical Co., Ltd. | 126.3 | 3.4 | 2.7% | 2026 |
| Kyowa Kirin Co., Ltd. | 297.3 | 32.4 | 10.9% | 2025 |
| Medrx Co.,Ltd. | 0.1 | -0.9 | -731.8% | 2025 |
| MIZUHO MEDY CO.,LTD. | 11.3 | 3.4 | 30.4% | 2025 |
| Mochida Pharmaceutical Co.,Ltd. | 117 | 7.9 | 6.8% | 2026 |
| Modalis Therapeutics Corporation | — | -2.2 | — | 2025 |
| MORISHITA JINTAN CO., LTD. | 12.7 | 0.6 | 4.9% | 2026 |
| MUROMACHI CHEMICALS INC. | 7.8 | 0.2 | 2.1% | 2026 |
| Nano Holdings, Inc. | 0.2 | -0.9 | -540.9% | 2026 |
| NIPPON CHEMIPHAR CO., LTD. | 33.1 | 0.2 | 0.6% | 2026 |
| Nippon Shinyaku Co., Ltd. | 166.1 | 33 | 19.9% | 2026 |
| Noile-Immune Biotech Inc. | — | -0.8 | — | 2025 |
| Nxera Pharma Co., Ltd. | 19 | -23.7 | -124.4% | 2025 |
| Oncolys BioPharma Inc. | 0 | -2.1 | -7,209.6% | 2025 |
| OncoTherapy Science, Inc. | 0 | -0.9 | -34,533.1% | 2026 |
| ONO PHARMACEUTICAL CO., LTD. | 458.9 | 79.7 | 17.4% | 2026 |
| Otsuka Holdings Co., Ltd. | — | 89.9 | — | 2025 |
| PeptiDream Inc. | 2.8 | -5.4 | -194.1% | 2025 |
| Perseus Proteomics Inc. | 0.1 | -0.7 | -529.9% | 2026 |
| PRISM BioLab Co.,LTD | 0.7 | -0.8 | -123.1% | 2025 |
| RaQualia Pharma Inc. | — | 0.3 | — | 2025 |
| Renascience Inc. | — | -0.3 | — | 2026 |
| RIBOMIC Inc. | — | -1.1 | — | 2026 |
| ROHTO PHARMACEUTICAL CO.,LTD. | 343.7 | 34.4 | 10% | 2026 |
| SanBio Company Limited | — | -3.8 | — | 2026 |
| SANTEN PHARMACEUTICAL CO., LTD. | 171.8 | 15.8 | 9.2% | 2026 |
| SAWAI GROUP HOLDINGS Co., Ltd. | — | 14.9 | — | 2026 |
| SEIKAGAKU CORPORATION | 36.6 | 1.5 | 4% | 2026 |
| Shionogi & Co., Ltd. | 388.5 | 138.9 | 35.7% | 2026 |
| Solasia Pharma K.K. | 0.4 | -0.9 | -209.1% | 2025 |
| STELLA PHARMA CORPORATION | 0.3 | -0.8 | -241.5% | 2026 |
| StemCell Institute Inc. | 2.8 | 0.1 | 4.7% | 2026 |
| StemRIM Inc. | — | -1.9 | — | 2025 |
| Sumitomo Pharma Co., Ltd. | 249.5 | 115 | 46.1% | 2026 |
| SymBio Pharmaceuticals Limited | 1.3 | -4.8 | -365.3% | 2025 |
| TAIKO PHARMACEUTICAL CO.,LTD. | 6.4 | 0.9 | 14.4% | 2025 |
| Takeda Pharmaceutical Company Limited | 591.6 | 197.3 | 33.4% | 2026 |
| TMS Co., Ltd. | — | -0.7 | — | 2025 |
| TOWA PHARMACEUTICAL CO., LTD. | 273.7 | 5.3 | 1.9% | 2026 |
| TSUMURA & CO. | 192.6 | 30.2 | 15.7% | 2026 |
| Veritas In Silico Inc. | — | -0.4 | — | 2025 |
| WAKAMOTO PHARMACEUTICAL CO.,LTD. | 9.9 | 0.2 | 2.3% | 2026 |
| Yuki Gosei Kogyo Co., Ltd. | 15.4 | 0.3 | 2% | 2026 |
| ZERIA PHARMACEUTICAL CO., LTD. | 89.2 | 8.4 | 9.4% | 2026 |